This filing concerns Athira Pharma, Inc. and reports beneficial ownership information as of November 18, 2025. The percentages are based on 9,604,313 shares of Common Stock outstanding. ACORN BIOVENTURES, L.P. holds 210,730 shares, representing 2.2% ownership. ACORN CAPITAL ADVISORS GP, LLC, as the general partner, may...

This filing reports that Skylark Partners I, LP has acquired a 5.4% ownership stake in ASTROTECH Corp as of September 29, 2025. The filing indicates that Skylark Partners I, LP beneficially owns 94,370 shares, with sole voting and dispositive power over these shares. The securities were not acquired or held for the pur...

Affinity Asset Advisors, LLC, as the investment manager for Affinity Healthcare Fund, LP, has reported beneficial ownership of 862,400 shares of Forte Biosciences, Inc. common stock, representing 6.9% of the outstanding shares as of November 7, 2025. This ownership also includes the exercise of call options for an addi...

This filing concerns Athira Pharma, Inc. and reports beneficial ownership information as of November 18, 2025. The percentages are based on 9,604,313 shares of Common Stock outstanding. ACORN BIOVENTURES, L.P. holds 210,730 shares, representing 2.2% ownership. ACORN CAPITAL ADVISORS GP, LLC, as the general partner, may...

Harel Insurance Investments & Financial Services Ltd. has acquired a 5.3% ownership in Camtek Ltd, amounting to 2,410,045 ordinary shares. This significant increase from a previous 0.0% ownership, with a reported value of $255,416,569.10, was effective as of December 19, 2025. The shares were acquired on December 23, 2...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G, reporting beneficial ownership of 5.3% of Churchill Capital Corp XI's Class A Ordinary Shares. The total number of shares beneficially owned is 2,224,879. The filing indicates that these securities a...

Lind Global Fund III LP, along with its general partner Lind Global Partners III LLC and its managing member Jeff Easton, have filed a Schedule 13G, reporting beneficial ownership of 197,494 shares of DEFSEC Technologies Inc. common stock. This constitutes 9.9% of the outstanding shares. The filing indicates that the r...

Pantera Capital Partners LP and Daniel Wayne Morehead have jointly filed a Schedule 13G, reporting beneficial ownership of 11,643,837 shares of Eightco Holdings Inc. common stock as of September 30, 2025. This represents 6.22% of the company's outstanding shares. The filing indicates that Pantera Capital Partners LP ma...

Linden Capital L.P., along with Linden GP LLC, Linden Advisors LP, and Siu Min Wong, collectively acting as Reporting Persons, have filed a Schedule 13G regarding their beneficial ownership of Evolution Global Acquisition Corp. As of December 22, 2025, Linden Capital L.P. and Linden GP LLC beneficially own approximatel...

Affinity Asset Advisors, LLC, as the investment manager for Affinity Healthcare Fund, LP, has reported beneficial ownership of 862,400 shares of Forte Biosciences, Inc. common stock, representing 6.9% of the outstanding shares as of November 7, 2025. This ownership also includes the exercise of call options for an addi...

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, reported beneficial ownership of 2,734,397 shares of Founder Group Ltd's Ordinary Shares as of December 23, 2025. This represents 9.99% of the outstanding shares. The ownership is subject to a contractual cap of 9.99%, which is aggrega...

Harel Insurance Investments & Financial Services Ltd. has acquired a 5.3% ownership in Camtek Ltd, amounting to 2,410,045 ordinary shares. This significant increase from a previous 0.0% ownership, with a reported value of $255,416,569.10, was effective as of December 19, 2025. The shares were acquired on December 23, 2...

Rorschach Advisors LLC, a Delaware limited liability company, has filed a Schedule 13G, reporting beneficial ownership of 9.99% of Hyperliquid Strategies Inc. common stock, amounting to 13,236,800 shares. This ownership includes 7,761,860 shares acquired at the closing of a business combination on December 2, 2025, and...

Linden Capital L.P., along with affiliated entities Linden GP LLC, Linden Advisors LP, and individual Siu Min Wong, has reported beneficial ownership of approximately 6.1% of the outstanding ordinary shares of Iron Horse Acquisition II Corp. as of December 18, 2025. Linden Capital L.P. holds 1,436,406 shares, while man...

Lind Global Fund III LP, along with its general partner Lind Global Partners III LLC and its managing member Jeff Easton, have filed a Schedule 13G, reporting beneficial ownership of 197,494 shares of DEFSEC Technologies Inc. common stock. This constitutes 9.9% of the outstanding shares. The filing indicates that the r...

Linden Capital L.P., along with affiliated entities Linden GP LLC, Linden Advisors LP, and individual Siu Min Wong, has reported beneficial ownership of approximately 6.1% of the outstanding ordinary shares of Iron Horse Acquisition II Corp. as of December 18, 2025. Linden Capital L.P. holds 1,436,406 shares, while man...

Linden Capital L.P., along with Linden GP LLC, Linden Advisors LP, and Siu Min Wong, collectively acting as Reporting Persons, have filed a Schedule 13G regarding their beneficial ownership of Evolution Global Acquisition Corp. As of December 22, 2025, Linden Capital L.P. and Linden GP LLC beneficially own approximatel...

Squadron Capital Management, LLC, along with Squadron Master Fund LP, Matthew Sesterhenn, and William Blank, has filed a Schedule 13G detailing their beneficial ownership of Lipocine Inc. common stock. Squadron Capital Management, LLC, acting as the investment adviser, may be deemed the beneficial owner of shares held ...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G, reporting beneficial ownership of 5.3% of Churchill Capital Corp XI's Class A Ordinary Shares. The total number of shares beneficially owned is 2,224,879. The filing indicates that these securities a...

Propel Bio Management, LLC, along with individuals Leen Kawas and Richard Kayne, and entity Propel Bio Partners LLC, collectively hold 9.99% of Milestone Pharmaceuticals Inc. common stock, amounting to 8,861,186 shares. This ownership is subject to a limitation where further exercise of warrants would exceed the 9.99% ...

Perceptive Advisors LLC, along with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., has filed a Schedule 13G, reporting beneficial ownership of 439,142 shares of Tenax Therapeutics, Inc. common stock. This represents 7.0% of the outstanding shares as of November 11, 2025. Perceptive Advisors acts as the ...

Pantera Capital Partners LP and Daniel Wayne Morehead have jointly filed a Schedule 13G, reporting beneficial ownership of 11,643,837 shares of Eightco Holdings Inc. common stock as of September 30, 2025. This represents 6.22% of the company's outstanding shares. The filing indicates that Pantera Capital Partners LP ma...

Propel Bio Management, LLC, along with individuals Leen Kawas and Richard Kayne, and entity Propel Bio Partners LLC, collectively hold 9.99% of Milestone Pharmaceuticals Inc. common stock, amounting to 8,861,186 shares. This ownership is subject to a limitation where further exercise of warrants would exceed the 9.99% ...

YA II PN, Ltd. has filed a Schedule 13G, reporting beneficial ownership of 508,723 American Depositary Shares (ADSs) of RedHill Biopharma Ltd. as of December 19, 2025. This represents 9.9% of the outstanding ADSs. The filing was made pursuant to a Standby Equity Distribution Agreement (SEPA) entered into on the same da...

Rorschach Advisors LLC, a Delaware limited liability company, has filed a Schedule 13G, reporting beneficial ownership of 9.99% of Hyperliquid Strategies Inc. common stock, amounting to 13,236,800 shares. This ownership includes 7,761,860 shares acquired at the closing of a business combination on December 2, 2025, and...